Celsius Therapeutics is a pioneering brand in the field of precision medicine, aiming to advance the treatment of inflammatory diseases. By harnessing the power of single-cell RNA sequencing and human biology at scale, Celsius is developing new precision medicines in this domain. With their expertise in single-cell genomics and machine learning, Celsius provides a high-resolution view into cellular programs associated with inflammatory disease, offering a deeper understanding of complex diseases.

Celsius' platform, SCOPE, allows them to observe cells in a specific therapeutic setting, generating unmatched insights into disease biology. Their automated machine learning platform enables the rapid delivery of these insights. Their first therapeutic candidate is an anti-TREM1 antibody, designed for the treatment of inflammatory bowel disease.

This target was identified through machine learning-enabled analysis of numerous clinical samples. Celsius understands the importance of collaboration and embraces a multidisciplinary approach. They value every viewpoint, knowing that innovation in precision medicine requires diverse perspectives.

If you're interested in joining their mission, Celsius has open positions available. Visit Celsius Therapeutics' headquarters at 399 Binney Street, 1st Floor, Cambridge, MA, or connect with them on Twitter and LinkedIn